Mendelian randomization of blood lipids for coronary heart disease

European Heart Journal

Volumn 36, Issue 9, 2015, Pages 539-550

  Holmes, Michael V ^a,b   Asselbergs, Folkert W ^a,c,d   Palmer, Tom M ^e   Drenos, Fotios ^a,f   Lanktree, Matthew B ^g   Nelson, Christopher P ^h,i   Dale, Caroline E ^j   Padmanabhan, Sandosh ^k   Finan, Chris ^a   Swerdlow, Daniel I ^a   Tragante, Vinicius ^c   Van Iperen, Erik P A ^d,l   Sivapalaratnam, Suthesh ^l   Shah, Sonia ^a   Elbers, Clara C ^c,m   Shah, Tina ^a   Engmann, Jorgen ^a   Giambartolomei, Claudia ^a   White, Jon ^a   Zabaneh, Delilah ^a   Sofat, Reecha ^a   McLachlan, Stela ⁿ   Doevendans, Pieter A ^c   Balmforth, Anthony J ^o   Hall, Alistair S ^o   North, Kari E ^p   Almoguera, Berta ^m   Hoogeveen, Ron C ^q   Cushman, Mary ^r,s   Fornage, Myriam ^t   Patel, Sanjay R ^u   Redline, Susan ^u   Siscovick, David S ^v,w   Tsai, Michael Y ^x   Karczewski, Konrad J ^y   Hofker, Marten H ^z   Verschuren, W Monique ^aa   Bots, Michiel L ^c   Van Der Schouw, Yvonne T ^c   Melander, Olle ^ab   Dominiczak, Anna F ^k   Morris, Richard ^a   Ben Shlomo, Yoav ^ac   Price, Jackie ⁿ   Kumari, Meena ^a   Baumert, Jens ^ad   Peters, Annette ^ad   Thorand, Barbara ^ad   Koenig, Wolfgang ^ae   Gaunt, Tom R ^f   Humphries, Steve E ^a   Clarke, Robert ^af   Watkins, Hugh ^af   Farrall, Martin ^af   Wilson, James G ^ag   Rich, Stephen S ^ah   De Bakker, Paul I W ^c   Lange, Leslie A ^ai   Smith, George Davey ^f   Reiner, Alex P ^aj   Talmud, Philippa J ^a   Kivimäki, Mika ^a   Lawlor, Debbie A ^f   Dudbridge, Frank ^j   Samani, Nilesh J ^h,i   Keating, Brendan J ^b,m   Hingorani, Aroon D ^a   Casas, Juan P ^a,j   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^e UNIVERSITY OF WARWICK   (United Kingdom)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

^g MCMASTER UNIVERSITY   (Canada)

^h UNIVERSITY OF LEICESTER   (United Kingdom)

ⁱ GLENFIELD HOSPITAL   (United Kingdom)

^j LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^k UNIVERSITY OF GLASGOW   (United Kingdom)

^l ACADEMIC MEDICAL CENTER   (Netherlands)

^m CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

ⁿ UNIVERSITY OF EDINBURGH   (United Kingdom)

^o UNIVERSITY OF LEEDS   (United Kingdom)

^p University of North Carolina at Chapel Hill   (United States)

^q BAYLOR COLLEGE OF MEDICINE   (United States)

^r UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^s UNIVERSITY OF VERMONT   (United States)

^t UNIVERSITY OF TEXAS   (United States)

^u BRIGHAM AND WOMEN S HOSPITAL   (United States)

^v UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^w UNIVERSITY OF WASHINGTON   (United States)

^x UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^y STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^z UNIVERSITY OF GRONINGEN   (Netherlands)

^aa NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^ab LUND UNIVERSITY   (Sweden)

^ac UNIVERSITY OF BRISTOL   (United Kingdom)

^ad INSTITUTE OF EPIDEMIOLOGY   (Germany)

^ae UNIVERSITY HOSPITAL ULM   (Germany)

^af UNIVERSITY OF OXFORD   (United Kingdom)

^ag UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^ah UNIVERSITY OF VIRGINIA   (United States)

^ai UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^aj USA   (United States)

more..

Author keywords

Aetiology; Epidemiology; Heart disease; Lipids; Mendelian randomization

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ALLELE; ARTICLE; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; MENDELIAN RANDOMIZATION ANALYSIS; META ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETICS; GENOTYPING TECHNIQUE; MALE; MIDDLE AGED; RISK ASSESSMENT;

CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; TRIGLYCERIDES;

EID: 84924420487     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht571     Document Type: Article

References (34)

1. Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R, Baigent C. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-Analysis of individual data from 27 randomised trials. Lancet 2012;380:581-590.
2. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R. Efficacy and safety of cholesterol-lowering treatment: prospective meta-Analysis of data from 90, 056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-1278.
3. Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, Collins R, Thompson SG, Danesh J. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009;302:1993-2000.
4. Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 2012;367:2089-2099.
5. Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, Drury P, Kesaniemi YA, Sullivan D, Hunt D, Colman P, dEmden M, Whiting M, Ehnholm C, Laakso M, investigators Fs. Effects of long-Term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005;366:1849-1861.
6. Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, Komajda M, Lopez-Sendon J, Mosca L, Tardif JC, Waters DD, Shear CL, Revkin JH, Buhr KA, Fisher MR, Tall AR, Brewer B, Investigators I. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007;357:2109-2122.
7. Wattanasuwan N, Khan IA, Gowda RM, Vasavada BC, Sacchi TJ. Effect of acute myocardial infarction on cholesterol ratios. Chest 2001;120:1196-1199.
8. Goldberg AS, Hegele RA. Cholesteryl ester transfer protein inhibitors for dyslipidemia: focus on dalcetrapib. Drug Des Devel Ther 2012;6:251-259.
9. Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey Smith G. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008;27:1133-1163.
10. Hingorani A, Humphries S. Natures randomised trials. Lancet 2005;366: 1906-1908.
11. Ference BA, Yoo W, Alesh I, Mahajan N, Mirowska KK, Mewada A, Kahn J, Afonso L, Williams KA Sr, Flack JM. Effect of long-Term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis. J Am Coll Cardiol 2012;60:2631-2639.
12. Kathiresan S, Melander O, Anevski D, Guiducci C, Burtt NP, Roos C, Hirschhorn JN, Berglund G, Hedblad B, Groop L, Altshuler DM, Newton-Cheh C, Orho-Melander M. Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med 2008;358:1240-1249.
13. Frikke-Schmidt R, Nordestgaard BG, Stene MC, Sethi AA, Remaley AT, Schnohr P, Grande P, Tybjaerg-Hansen A. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. JAMA 2008;299:2524-2532.
14. Johannsen TH, Kamstrup PR, Andersen RV, Jensen GB, Sillesen H, Tybjaerg-Hansen A, Nordestgaard BG. Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease. J Clin Endocrinol Metab 2009;94: 1264-1273.
15. Haase CL, Tybjaerg-Hansen A, Grande P, Frikke-Schmidt R. Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease. J Clin Endocrinol Metab 2010;95:E500-E510.
16. Voight BF, Peloso GM, Orho-Melander M, Frikke-Schmidt R, Barbalic M, Jensen MK, Hindy G, Holm H, Ding EL, Johnson T, Schunkert H, Samani NJ, Clarke R, Hopewell JC, Thompson JF, Li M, Thorleifsson G, Newton-Cheh C, Musunuru K, Pirruccello JP, Saleheen D, Chen L, Stewart A, Schillert A, Thorsteinsdottir U, Thorgeirsson G, Anand S, Engert JC, Morgan T, Spertus J, Stoll M, Berger K, Martinelli N, Girelli D, McKeown PP, Patterson CC. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 2012;380:572-580.
17. Triglyceride Coronary Disease Genetics C, Emerging Risk Factors C, Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, Boekholdt SM, Ouwehand W, Watkins H, Samani NJ, Saleheen D, Lawlor D, Reilly MP, Hingorani AD, Talmud PJ, Danesh J. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet 2010;375:1634-1639.
18. Waterworth DM, Ricketts SL, Song K, Chen L, Zhao JH, Ripatti S, Aulchenko YS, Zhang W, Yuan X, Lim N, Luan J, Ashford S, Wheeler E, Young EH, Hadley D, Thompson JR, Braund PS, Johnson T, Struchalin M, Surakka I, Luben R, Khaw KT, Rodwell SA, Loos RJ, Boekholdt SM, Inouye M, Deloukas P, Elliott P, Schlessinger D, Sanna S, Scuteri A, Jackson A, Mohlke KL, Tuomilehto J, Roberts R, Stewart A, Kesaniemi YA, Mahley RW, Grundy SM, McArdle W, Cardon L, Waeber G, Vollenweider P. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol 2010;30: 2264-2276.
19. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Pirruccello JP, Ripatti S, Chasman DI, Willer CJ, Johansen CT, Fouchier SW, Isaacs A, Peloso GM, Barbalic M, Ricketts SL, Bis JC, Aulchenko YS, Thorleifsson G, Feitosa MF, Chambers J, Orho-Melander M, Melander O, Johnson T, Li X, Guo X, Li M, Shin Cho Y, Jin Go M, Jin Kim Y. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010;466:707-713.
20. Holmes MV, Harrison S, Talmud PJ, Hingorani AD, Humphries SE. Utility of genetic determinants of lipids and cardiovascular events in assessing risk. Nat Rev Cardiol 2011;8:207-221.
21. Asselbergs FW, Guo Y, van Iperen EP, Sivapalaratnam S, Tragante V, Lanktree MB, Lange LA, Almoguera B, Appelman YE, Barnard J, Baumert J, Beitelshees AL, Bhangale TR, Chen YD, Gaunt TR, Gong Y, Hopewell JC, Johnson T, Kleber ME, Langaee TY, Li M. Large-scale genecentric meta-Analysis across 32 studies identifies multiple lipid loci. Am J Hum Genet 2012;91:823-838.
22. Palmer TM, Lawlor DA, Harbord RM, Sheehan NA, Tobias JH, Timpson NJ, Davey Smith G, Sterne JA. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res 2012;21:223-242.
23. Keating BJ, Tischfield S, Murray SS, Bhangale T, Price TS, Glessner JT, Galver L, Barrett JC, Grant SF, Farlow DN, Chandrupatla HR, Hansen M, Ajmal S, Papanicolaou GJ, Guo Y, Li M, Derohannessian S, de Bakker PI, Bailey SD, Montpetit A, Edmondson AC, Taylor K, Gai X, Wang SS, Fornage M, Shaikh T, Groop L, Boehnke M, Hall AS, Hattersley AT, Frackelton E, Patterson N, Chiang CW, Kim CE, Fabsitz RR, Ouwehand W, Price AL, Munroe P, Caulfield M, Drake T, Boerwinkle E, Reich D, Whitehead AS, Cappola TP, Samani NJ, Lusis AJ, Schadt E, Wilson JG, Koenig W, McCarthy MI, Kathiresan S, Gabriel SB, Hakonarson H, Anand SS, Reilly M, Engert JC, Nickerson DA, Rader DJ, Hirschhorn JN, Fitzgerald GA. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS One 2008;3:e3583.
24. Palmer TM, Sterne JA, Harbord RM, Lawlor DA, Sheehan NA, Meng S, Granell R, Smith GD, Didelez V. Instrumental variable estimation of causal risk ratios and causal odds ratios in Mendelian randomization analyses. Am J Epidemiol 2011;173: 1392-1403.
25. Burgess S, Thompson SG. Use of allele scores as instrumental variables for Mendelian randomization. Int J Epidemiol 2013;42:1134-1144.
26. Voight BF, Kang HM, Ding J, Palmer CD, Sidore C, Chines PS, Burtt NP, Fuchsberger C, Li Y, Erdmann J, Frayling TM, Heid IM, Jackson AU, Johnson T, Kilpelainen TO, Lindgren CM, Morris AP, Prokopenko I, Randall JC, Saxena R, Soranzo N, Speliotes EK, Teslovich TM, Wheeler E, Maguire J, Parkin M, Potter S, Rayner NW, Robertson N, Stirrups K, Winckler W, Sanna S, Mulas A, Nagaraja R, Cucca F, Barroso I, Deloukas P, Loos RJ, Kathiresan S, Munroe PB, Newton-Cheh C, Pfeufer A, Samani NJ, Schunkert H, Hirschhorn JN, Altshuler D, McCarthy MI, Abecasis GR, Boehnke M. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet 2012;8:e1002793.
27. Kaiser J. DNA sequencing. A plan to capture human diversity in 1000 genomes. Science 2008;319:395.
28. Bots ML, Visseren FL, Evans GW, Riley WA, Revkin JH, Tegeler CH, Shear CL, Duggan WT, Vicari RM, Grobbee DE, Kastelein JJ, Investigators R. Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial. Lancet 2007;370:153-160.
29. Angrist JD, Krueger AB. Split-sample instrumental variables estimates of the return to schooling. J Bus Econ Stat 1995;13:225-235.
30. Thomas DC, Lawlor DA, Thompson JR. Re: Estimation of bias in nongenetic observational studies using Mendelian triangulation by Bautista LE, Smeeth L, Hingorani AD, Casas JP. Ann Epidemiol 2007;17:511-513.
31. Shah S, Casas JP, Drenos F, Whittaker J, Deanfield J, Swerdlow DI, Holmes MV, Kivimaki M, Langenberg C, Wareham N, Gertow K, Sennblad B, Strawbridge RJ, Baldassarre D, Veglia F, Tremol E, Gigante B, De Faire U, Kumari M, Talmud PJ, Hamsten A, Humphries SE, Hingorani AD. Causal relevance of blood lipid fractions in the development of carotid atherosclerosis: Mendelian randomization analysis. Circ Cardiovasc Gen 2013;6:63-72.
32. Wurtz P, Kangas AJ, Soininen P, Lehtimaki T, Kahonen M, Viikari JS, Raitakari OT, Jarvelin MR, Davey Smith G, Ala-Korpela M. Lipoprotein subclass profiling reveals pleiotropy in the genetic variants of lipid risk factors for coronary heart disease: a note on mendelian randomization studies. J Am Coll Cardiol 2013;62:1906-1908.
33. Varbo A, Benn M, Tybjaerg-Hansen A, Jorgensen AB, Frikke-Schmidt R, Nordestgaard BG. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol 2013;61:427-436.
34. Wurtz P, Raiko JR, Magnussen CG, Soininen P, Kangas AJ, Tynkkynen T, Thomson R, Laatikainen R, Savolainen MJ, Laurikka J, Kuukasjarvi P, Tarkka M, Karhunen PJ, Jula A, Viikari JS, Kahonen M, Lehtimaki T, Juonala M, Ala-Korpela M, Raitakari OT. Highthroughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis. Eur Heart J 2012;33:2307-2316.